151 related articles for article (PubMed ID: 25527118)
1. Pharmacokinetics of treosulfan and its active monoepoxide in pediatric patients after intravenous infusion of high-dose treosulfan prior to HSCT.
Główka F; Kasprzyk A; Romański M; Wróbel T; Wachowiak J; Szpecht D; Kałwak K; Wiela-Hojeńska A; Dziatkiewicz P; Teżyk A; Żaba C
Eur J Pharm Sci; 2015 Feb; 68():87-93. PubMed ID: 25527118
[TBL] [Abstract][Full Text] [Related]
2. Disposition of treosulfan and its active monoepoxide in a bone marrow, liver, lungs, brain, and muscle: Studies in a rat model with clinical relevance.
Romański M; Kasprzyk A; Walczak M; Ziółkowska A; Główka F
Eur J Pharm Sci; 2017 Nov; 109():616-623. PubMed ID: 28916482
[TBL] [Abstract][Full Text] [Related]
3. Relationship between exposure to treosulfan and its monoepoxytransformer - An insight from population pharmacokinetic study in pediatric patients before hematopoietic stem cell transplantation.
Danielak D; Kasprzyk A; Wróbel T; Wachowiak J; Kałwak K; Główka F
Eur J Pharm Sci; 2018 Jul; 120():1-9. PubMed ID: 29705215
[TBL] [Abstract][Full Text] [Related]
4. Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of protein-free pro-drug treosulfan and its biologically active monoepoxy-transformer in plasma and brain tissue.
Romański M; Teżyk A; Zaba C; Główka FK
Talanta; 2014 Sep; 127():123-32. PubMed ID: 24913866
[TBL] [Abstract][Full Text] [Related]
5. Formation Rate-Limited Pharmacokinetics of Biologically Active Epoxy Transformers of Prodrug Treosulfan.
Romański M; Kasprzyk A; Karbownik A; Szałek E; Główka FK
J Pharm Sci; 2016 May; 105(5):1790-1797. PubMed ID: 27044946
[TBL] [Abstract][Full Text] [Related]
6. Penetration of Treosulfan and its Active Monoepoxide Transformation Product into Central Nervous System of Juvenile and Young Adult Rats.
Romański M; Baumgart J; Böhm S; Główka FK
Drug Metab Dispos; 2015 Dec; 43(12):1946-54. PubMed ID: 26428246
[TBL] [Abstract][Full Text] [Related]
7. Activation of Prodrug Treosulfan at pH 7.4 and 37°C Accompanied by Hydrolysis of Its Active Epoxides: Kinetic Studies with Clinical Relevance.
Romański M; Urbaniak B; Kokot Z; Główka FK
J Pharm Sci; 2015 Dec; 104(12):4433-4442. PubMed ID: 26422826
[TBL] [Abstract][Full Text] [Related]
8. Treosulfan Pharmacokinetics and its Variability in Pediatric and Adult Patients Undergoing Conditioning Prior to Hematopoietic Stem Cell Transplantation: Current State of the Art, In-Depth Analysis, and Perspectives.
Romański M; Wachowiak J; Główka FK
Clin Pharmacokinet; 2018 Oct; 57(10):1255-1265. PubMed ID: 29557088
[TBL] [Abstract][Full Text] [Related]
9. Determination of prodrug treosulfan and its biologically active monoepoxide in rat plasma, liver, lungs, kidneys, muscle, and brain by HPLC-ESI-MS/MS method.
Romański M; Kasprzyk A; Teżyk A; Widerowska A; Żaba C; Główka F
J Pharm Biomed Anal; 2017 Jun; 140():122-129. PubMed ID: 28346882
[TBL] [Abstract][Full Text] [Related]
10. Ocular disposition of treosulfan and its active epoxy-transformers following intravenous administration in rabbits.
Romański M; Kasprzyk A; Karbownik A; Główka FK
Drug Metab Pharmacokinet; 2016 Oct; 31(5):356-362. PubMed ID: 27662779
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation.
Danielak D; Twardosz J; Kasprzyk A; Wachowiak J; Kałwak K; Główka F
Eur J Clin Pharmacol; 2018 Jan; 74(1):79-89. PubMed ID: 28975382
[TBL] [Abstract][Full Text] [Related]
12. Determination of partition coefficients n-octanol/water for treosulfan and its epoxy-transformers: an example of a negative correlation between lipophilicity of unionized compounds and their retention in reversed-phase chromatography.
Główka FK; Romański M; Siemiątkowska A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():92-7. PubMed ID: 23500352
[TBL] [Abstract][Full Text] [Related]
13. Effect of Temperature on the Kinetics of the Activation of Treosulfan and Hydrolytic Decomposition of Its Active Epoxy Derivatives.
Romański M; Mikołajewski J; Główka FK
J Pharm Sci; 2017 Oct; 106(10):3156-3160. PubMed ID: 28600186
[TBL] [Abstract][Full Text] [Related]
14. HPLC method for determination of biologically active epoxy-transformers of treosulfan in human plasma: pharmacokinetic application.
Główka FK; Romański M; Teżyk A; Zaba C; Wróbel T
J Pharm Biomed Anal; 2012 Mar; 62():105-13. PubMed ID: 22260969
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Mohanan E; Panetta JC; Lakshmi KM; Edison ES; Korula A; Na F; Abraham A; Viswabandya A; George B; Mathews V; Srivastava A; Balasubramanian P
Clin Pharmacol Ther; 2018 Sep; 104(3):575-583. PubMed ID: 29247522
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.
Główka FK; Karaźniewicz-Łada M; Grund G; Wróbel T; Wachowiak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S67-70. PubMed ID: 18978748
[TBL] [Abstract][Full Text] [Related]
17. High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation.
Główka FK; Romański M; Wachowiak J
Expert Opin Investig Drugs; 2010 Oct; 19(10):1275-95. PubMed ID: 20836619
[TBL] [Abstract][Full Text] [Related]
18. Direct high-performance liquid chromatography method with refractometric detection designed for stability studies of treosulfan and its biologically active epoxy-transformers.
Główka FK; Romański M; Teżyk A; Żaba C
J Pharm Biomed Anal; 2013 Jan; 72():145-9. PubMed ID: 23146239
[TBL] [Abstract][Full Text] [Related]
19. Clinical bioanalysis of treosulfan and its epoxides: The importance of collected blood processing for valid pharmacokinetic results.
Romański M; Główka F
J Pharm Biomed Anal; 2018 May; 153():199-203. PubMed ID: 29501039
[TBL] [Abstract][Full Text] [Related]
20. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
